502 related articles for article (PubMed ID: 23781007)
1. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
Williams-Gray CH; Mason SL; Evans JR; Foltynie T; Brayne C; Robbins TW; Barker RA
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1258-64. PubMed ID: 23781007
[TBL] [Abstract][Full Text] [Related]
2. The natural history of treated Parkinson's disease in an incident, community based cohort.
Evans JR; Mason SL; Williams-Gray CH; Foltynie T; Brayne C; Robbins TW; Barker RA
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1112-8. PubMed ID: 21593513
[TBL] [Abstract][Full Text] [Related]
3. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.
Williams-Gray CH; Evans JR; Goris A; Foltynie T; Ban M; Robbins TW; Brayne C; Kolachana BS; Weinberger DR; Sawcer SJ; Barker RA
Brain; 2009 Nov; 132(Pt 11):2958-69. PubMed ID: 19812213
[TBL] [Abstract][Full Text] [Related]
4. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
Burn DJ; Rowan EN; Allan LM; Molloy S; O'Brien JT; McKeith IG
J Neurol Neurosurg Psychiatry; 2006 May; 77(5):585-9. PubMed ID: 16614017
[TBL] [Abstract][Full Text] [Related]
5. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
Hobson P; Meara J
BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
[TBL] [Abstract][Full Text] [Related]
6. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.
Williams-Gray CH; Foltynie T; Brayne CE; Robbins TW; Barker RA
Brain; 2007 Jul; 130(Pt 7):1787-98. PubMed ID: 17535834
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.
Keener AM; Paul KC; Folle A; Bronstein JM; Ritz B
J Parkinsons Dis; 2018; 8(2):353-362. PubMed ID: 29843251
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment in Parkinson's disease.
Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; Middelkoop HA; van Hilten JJ
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1182-7. PubMed ID: 17442759
[TBL] [Abstract][Full Text] [Related]
9. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients.
Auyeung M; Tsoi TH; Mok V; Cheung CM; Lee CN; Li R; Yeung E
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):607-11. PubMed ID: 22362919
[TBL] [Abstract][Full Text] [Related]
10. Motor and non-motor function predictors of mortality in Parkinson's disease.
Bugalho P; Ladeira F; Barbosa R; Marto JP; Borbinha C; Salavisa M; da Conceição L; Saraiva M; Fernandes M; Meira B
J Neural Transm (Vienna); 2019 Nov; 126(11):1409-1415. PubMed ID: 31385098
[TBL] [Abstract][Full Text] [Related]
11. PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study.
Bäckström D; Domellöf ME; Granåsen G; Linder J; Mayans S; Elgh E; Mo SJ; Forsgren L
J Neurol Sci; 2017 Oct; 381():278-284. PubMed ID: 28991698
[TBL] [Abstract][Full Text] [Related]
12. Postural instability and gait are associated with severity and prognosis of Parkinson disease.
van der Heeden JF; Marinus J; Martinez-Martin P; Rodriguez-Blazquez C; Geraedts VJ; van Hilten JJ
Neurology; 2016 Jun; 86(24):2243-50. PubMed ID: 27178702
[TBL] [Abstract][Full Text] [Related]
13. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
[TBL] [Abstract][Full Text] [Related]
14. How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study.
Gago MF; Garrett MC; Fonseca MR; Rosas MJ; Simões MF; Vieira S; Botelho F
J Neurol; 2009 Oct; 256(10):1655-62. PubMed ID: 19471849
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for early mortality in Parkinson's disease.
Oosterveld LP; Allen JC; Reinoso G; Seah SH; Tay KY; Au WL; Tan LC
Parkinsonism Relat Disord; 2015 Mar; 21(3):226-30. PubMed ID: 25572499
[TBL] [Abstract][Full Text] [Related]
17. Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.
Zhu K; van Hilten JJ; Marinus J
Parkinsonism Relat Disord; 2014 Sep; 20(9):980-5. PubMed ID: 25024059
[TBL] [Abstract][Full Text] [Related]
18. The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson's disease and controls.
Counsell C; Giuntoli C; Khan QI; Maple-Grødem J; Macleod AD
J Neurol; 2022 Aug; 269(8):4288-4298. PubMed ID: 35307754
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
